Skip to main content

Table 5 This table depicts the reporting odds ratio (ROR) for the top 10 reported medications from 2015–2020

From: Medication-induced osteonecrosis of the jaw: a review of cases from the Food and Drug Administration Adverse Event Reporting System (FAERS)

Medication

Reporting Odds Ratio (ROR)

1. Denosumab

129.3

2. Zoledronic Acid

380.9

3. Alendronate

80.2

4. Ibandronate

45.0

5. Lenalidomide

1.8

6. Pamidronate

255.7

7. Bevacizumab

6.2

8. Prednisolone

5.3

9. Risedronate

52.3

10. Dexamethasone

3.9